nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—ABCC4—Methotrexate—psoriatic arthritis	0.145	0.305	CbGbCtD
Dipyridamole—ABCB1—Methylprednisolone—psoriatic arthritis	0.0926	0.194	CbGbCtD
Dipyridamole—ABCB1—Betamethasone—psoriatic arthritis	0.0602	0.126	CbGbCtD
Dipyridamole—ABCB1—Prednisolone—psoriatic arthritis	0.0594	0.125	CbGbCtD
Dipyridamole—ABCB1—Prednisone—psoriatic arthritis	0.0561	0.118	CbGbCtD
Dipyridamole—ABCB1—Dexamethasone—psoriatic arthritis	0.035	0.0735	CbGbCtD
Dipyridamole—ABCB1—Methotrexate—psoriatic arthritis	0.0281	0.0591	CbGbCtD
Dipyridamole—Syncope—Methylprednisolone—psoriatic arthritis	0.00123	0.00235	CcSEcCtD
Dipyridamole—Oedema—Prednisolone—psoriatic arthritis	0.00122	0.00233	CcSEcCtD
Dipyridamole—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00122	0.00233	CcSEcCtD
Dipyridamole—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00121	0.00231	CcSEcCtD
Dipyridamole—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00121	0.0023	CcSEcCtD
Dipyridamole—Shock—Prednisolone—psoriatic arthritis	0.0012	0.00229	CcSEcCtD
Dipyridamole—Cough—Triamcinolone—psoriatic arthritis	0.0012	0.00229	CcSEcCtD
Dipyridamole—Convulsion—Triamcinolone—psoriatic arthritis	0.00119	0.00228	CcSEcCtD
Dipyridamole—Tachycardia—Prednisolone—psoriatic arthritis	0.00119	0.00228	CcSEcCtD
Dipyridamole—Convulsion—Methylprednisolone—psoriatic arthritis	0.00119	0.00227	CcSEcCtD
Dipyridamole—Hypertension—Triamcinolone—psoriatic arthritis	0.00119	0.00227	CcSEcCtD
Dipyridamole—Hypertension—Methylprednisolone—psoriatic arthritis	0.00119	0.00226	CcSEcCtD
Dipyridamole—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00118	0.00225	CcSEcCtD
Dipyridamole—Myalgia—Triamcinolone—psoriatic arthritis	0.00117	0.00224	CcSEcCtD
Dipyridamole—Myalgia—Methylprednisolone—psoriatic arthritis	0.00117	0.00223	CcSEcCtD
Dipyridamole—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00117	0.00223	CcSEcCtD
Dipyridamole—Anxiety—Methylprednisolone—psoriatic arthritis	0.00116	0.00222	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00116	0.00222	CcSEcCtD
Dipyridamole—Flushing—Prednisone—psoriatic arthritis	0.00116	0.00221	CcSEcCtD
Dipyridamole—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00116	0.00221	CcSEcCtD
Dipyridamole—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00116	0.00221	CcSEcCtD
Dipyridamole—Discomfort—Triamcinolone—psoriatic arthritis	0.00116	0.00221	CcSEcCtD
Dipyridamole—Discomfort—Methylprednisolone—psoriatic arthritis	0.00115	0.00221	CcSEcCtD
Dipyridamole—Dry mouth—Triamcinolone—psoriatic arthritis	0.00115	0.00219	CcSEcCtD
Dipyridamole—Angioedema—Betamethasone—psoriatic arthritis	0.00114	0.00218	CcSEcCtD
Dipyridamole—Angioedema—Dexamethasone—psoriatic arthritis	0.00114	0.00218	CcSEcCtD
Dipyridamole—Angiopathy—Prednisone—psoriatic arthritis	0.00113	0.00216	CcSEcCtD
Dipyridamole—Immune system disorder—Prednisone—psoriatic arthritis	0.00113	0.00215	CcSEcCtD
Dipyridamole—Malaise—Dexamethasone—psoriatic arthritis	0.00113	0.00215	CcSEcCtD
Dipyridamole—Malaise—Betamethasone—psoriatic arthritis	0.00113	0.00215	CcSEcCtD
Dipyridamole—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00112	0.00214	CcSEcCtD
Dipyridamole—Oedema—Triamcinolone—psoriatic arthritis	0.00112	0.00214	CcSEcCtD
Dipyridamole—Vertigo—Dexamethasone—psoriatic arthritis	0.00112	0.00214	CcSEcCtD
Dipyridamole—Vertigo—Betamethasone—psoriatic arthritis	0.00112	0.00214	CcSEcCtD
Dipyridamole—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00112	0.00214	CcSEcCtD
Dipyridamole—Syncope—Betamethasone—psoriatic arthritis	0.00112	0.00214	CcSEcCtD
Dipyridamole—Syncope—Dexamethasone—psoriatic arthritis	0.00112	0.00214	CcSEcCtD
Dipyridamole—Arrhythmia—Prednisone—psoriatic arthritis	0.00112	0.00213	CcSEcCtD
Dipyridamole—Shock—Triamcinolone—psoriatic arthritis	0.0011	0.00211	CcSEcCtD
Dipyridamole—Alopecia—Prednisone—psoriatic arthritis	0.0011	0.00211	CcSEcCtD
Dipyridamole—Shock—Methylprednisolone—psoriatic arthritis	0.0011	0.00211	CcSEcCtD
Dipyridamole—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.0011	0.0021	CcSEcCtD
Dipyridamole—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.0011	0.0021	CcSEcCtD
Dipyridamole—Loss of consciousness—Betamethasone—psoriatic arthritis	0.0011	0.0021	CcSEcCtD
Dipyridamole—Paraesthesia—Prednisolone—psoriatic arthritis	0.0011	0.00209	CcSEcCtD
Dipyridamole—Tachycardia—Triamcinolone—psoriatic arthritis	0.0011	0.00209	CcSEcCtD
Dipyridamole—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00109	0.00209	CcSEcCtD
Dipyridamole—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00109	0.00208	CcSEcCtD
Dipyridamole—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00109	0.00207	CcSEcCtD
Dipyridamole—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00108	0.00207	CcSEcCtD
Dipyridamole—Convulsion—Dexamethasone—psoriatic arthritis	0.00108	0.00207	CcSEcCtD
Dipyridamole—Convulsion—Betamethasone—psoriatic arthritis	0.00108	0.00207	CcSEcCtD
Dipyridamole—Hypertension—Betamethasone—psoriatic arthritis	0.00108	0.00206	CcSEcCtD
Dipyridamole—Hypertension—Dexamethasone—psoriatic arthritis	0.00108	0.00206	CcSEcCtD
Dipyridamole—Myalgia—Dexamethasone—psoriatic arthritis	0.00106	0.00203	CcSEcCtD
Dipyridamole—Myalgia—Betamethasone—psoriatic arthritis	0.00106	0.00203	CcSEcCtD
Dipyridamole—Anxiety—Betamethasone—psoriatic arthritis	0.00106	0.00202	CcSEcCtD
Dipyridamole—Anxiety—Dexamethasone—psoriatic arthritis	0.00106	0.00202	CcSEcCtD
Dipyridamole—Discomfort—Dexamethasone—psoriatic arthritis	0.00105	0.00201	CcSEcCtD
Dipyridamole—Discomfort—Betamethasone—psoriatic arthritis	0.00105	0.00201	CcSEcCtD
Dipyridamole—Haemoglobin—Methotrexate—psoriatic arthritis	0.00105	0.002	CcSEcCtD
Dipyridamole—Hypotension—Methylprednisolone—psoriatic arthritis	0.00105	0.002	CcSEcCtD
Dipyridamole—Pain—Prednisolone—psoriatic arthritis	0.00104	0.00199	CcSEcCtD
Dipyridamole—Haemorrhage—Methotrexate—psoriatic arthritis	0.00104	0.00199	CcSEcCtD
Dipyridamole—Hepatitis—Methotrexate—psoriatic arthritis	0.00104	0.00199	CcSEcCtD
Dipyridamole—Pharyngitis—Methotrexate—psoriatic arthritis	0.00104	0.00198	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00102	0.00195	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00102	0.00195	CcSEcCtD
Dipyridamole—Oedema—Betamethasone—psoriatic arthritis	0.00102	0.00195	CcSEcCtD
Dipyridamole—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00102	0.00195	CcSEcCtD
Dipyridamole—Oedema—Dexamethasone—psoriatic arthritis	0.00102	0.00195	CcSEcCtD
Dipyridamole—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00102	0.00195	CcSEcCtD
Dipyridamole—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00101	0.00193	CcSEcCtD
Dipyridamole—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00101	0.00193	CcSEcCtD
Dipyridamole—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00101	0.00192	CcSEcCtD
Dipyridamole—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00101	0.00192	CcSEcCtD
Dipyridamole—Anaemia—Prednisone—psoriatic arthritis	0.001	0.00192	CcSEcCtD
Dipyridamole—Shock—Betamethasone—psoriatic arthritis	0.001	0.00191	CcSEcCtD
Dipyridamole—Shock—Dexamethasone—psoriatic arthritis	0.001	0.00191	CcSEcCtD
Dipyridamole—Dyspnoea—Triamcinolone—psoriatic arthritis	0.001	0.00191	CcSEcCtD
Dipyridamole—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000999	0.00191	CcSEcCtD
Dipyridamole—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000999	0.00191	CcSEcCtD
Dipyridamole—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000998	0.00191	CcSEcCtD
Dipyridamole—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000998	0.00191	CcSEcCtD
Dipyridamole—Tachycardia—Betamethasone—psoriatic arthritis	0.000995	0.0019	CcSEcCtD
Dipyridamole—Tachycardia—Dexamethasone—psoriatic arthritis	0.000995	0.0019	CcSEcCtD
Dipyridamole—Angioedema—Prednisone—psoriatic arthritis	0.000994	0.0019	CcSEcCtD
Dipyridamole—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000989	0.00189	CcSEcCtD
Dipyridamole—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000986	0.00188	CcSEcCtD
Dipyridamole—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000985	0.00188	CcSEcCtD
Dipyridamole—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000985	0.00188	CcSEcCtD
Dipyridamole—Malaise—Prednisone—psoriatic arthritis	0.000981	0.00187	CcSEcCtD
Dipyridamole—Vertigo—Prednisone—psoriatic arthritis	0.000977	0.00187	CcSEcCtD
Dipyridamole—Syncope—Prednisone—psoriatic arthritis	0.000975	0.00186	CcSEcCtD
Dipyridamole—Tinnitus—Methotrexate—psoriatic arthritis	0.000973	0.00186	CcSEcCtD
Dipyridamole—Urticaria—Prednisolone—psoriatic arthritis	0.00097	0.00185	CcSEcCtD
Dipyridamole—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000969	0.00185	CcSEcCtD
Dipyridamole—Fatigue—Triamcinolone—psoriatic arthritis	0.000968	0.00185	CcSEcCtD
Dipyridamole—Fatigue—Methylprednisolone—psoriatic arthritis	0.000966	0.00185	CcSEcCtD
Dipyridamole—Pain—Triamcinolone—psoriatic arthritis	0.00096	0.00183	CcSEcCtD
Dipyridamole—Loss of consciousness—Prednisone—psoriatic arthritis	0.000956	0.00183	CcSEcCtD
Dipyridamole—Hypotension—Betamethasone—psoriatic arthritis	0.000952	0.00182	CcSEcCtD
Dipyridamole—Hypotension—Dexamethasone—psoriatic arthritis	0.000952	0.00182	CcSEcCtD
Dipyridamole—Angiopathy—Methotrexate—psoriatic arthritis	0.000947	0.00181	CcSEcCtD
Dipyridamole—Immune system disorder—Methotrexate—psoriatic arthritis	0.000943	0.0018	CcSEcCtD
Dipyridamole—Convulsion—Prednisone—psoriatic arthritis	0.000942	0.0018	CcSEcCtD
Dipyridamole—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000941	0.0018	CcSEcCtD
Dipyridamole—Hypertension—Prednisone—psoriatic arthritis	0.000939	0.00179	CcSEcCtD
Dipyridamole—Chills—Methotrexate—psoriatic arthritis	0.000937	0.00179	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000928	0.00177	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000928	0.00177	CcSEcCtD
Dipyridamole—Myalgia—Prednisone—psoriatic arthritis	0.000926	0.00177	CcSEcCtD
Dipyridamole—Arthralgia—Prednisone—psoriatic arthritis	0.000926	0.00177	CcSEcCtD
Dipyridamole—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000925	0.00177	CcSEcCtD
Dipyridamole—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000923	0.00176	CcSEcCtD
Dipyridamole—Anxiety—Prednisone—psoriatic arthritis	0.000923	0.00176	CcSEcCtD
Dipyridamole—Alopecia—Methotrexate—psoriatic arthritis	0.000922	0.00176	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000919	0.00176	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000916	0.00175	CcSEcCtD
Dipyridamole—Paraesthesia—Betamethasone—psoriatic arthritis	0.000915	0.00175	CcSEcCtD
Dipyridamole—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000915	0.00175	CcSEcCtD
Dipyridamole—Discomfort—Prednisone—psoriatic arthritis	0.000915	0.00175	CcSEcCtD
Dipyridamole—Hypersensitivity—Prednisolone—psoriatic arthritis	0.0009	0.00172	CcSEcCtD
Dipyridamole—Dyspepsia—Betamethasone—psoriatic arthritis	0.000897	0.00171	CcSEcCtD
Dipyridamole—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000897	0.00171	CcSEcCtD
Dipyridamole—Urticaria—Triamcinolone—psoriatic arthritis	0.000892	0.0017	CcSEcCtD
Dipyridamole—Urticaria—Methylprednisolone—psoriatic arthritis	0.00089	0.0017	CcSEcCtD
Dipyridamole—Dysgeusia—Methotrexate—psoriatic arthritis	0.00089	0.0017	CcSEcCtD
Dipyridamole—Oedema—Prednisone—psoriatic arthritis	0.000887	0.00169	CcSEcCtD
Dipyridamole—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000887	0.00169	CcSEcCtD
Dipyridamole—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000886	0.00169	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00088	0.00168	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00088	0.00168	CcSEcCtD
Dipyridamole—Back pain—Methotrexate—psoriatic arthritis	0.000879	0.00168	CcSEcCtD
Dipyridamole—Fatigue—Betamethasone—psoriatic arthritis	0.000879	0.00168	CcSEcCtD
Dipyridamole—Fatigue—Dexamethasone—psoriatic arthritis	0.000879	0.00168	CcSEcCtD
Dipyridamole—Shock—Prednisone—psoriatic arthritis	0.000873	0.00167	CcSEcCtD
Dipyridamole—Pain—Dexamethasone—psoriatic arthritis	0.000871	0.00166	CcSEcCtD
Dipyridamole—Pain—Betamethasone—psoriatic arthritis	0.000871	0.00166	CcSEcCtD
Dipyridamole—Nervous system disorder—Prednisone—psoriatic arthritis	0.00087	0.00166	CcSEcCtD
Dipyridamole—Tachycardia—Prednisone—psoriatic arthritis	0.000866	0.00165	CcSEcCtD
Dipyridamole—Skin disorder—Prednisone—psoriatic arthritis	0.000862	0.00165	CcSEcCtD
Dipyridamole—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000858	0.00164	CcSEcCtD
Dipyridamole—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000843	0.00161	CcSEcCtD
Dipyridamole—Anaemia—Methotrexate—psoriatic arthritis	0.00084	0.0016	CcSEcCtD
Dipyridamole—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00084	0.0016	CcSEcCtD
Dipyridamole—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00084	0.0016	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000833	0.00159	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000833	0.00159	CcSEcCtD
Dipyridamole—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000827	0.00158	CcSEcCtD
Dipyridamole—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000826	0.00158	CcSEcCtD
Dipyridamole—Malaise—Methotrexate—psoriatic arthritis	0.000819	0.00157	CcSEcCtD
Dipyridamole—Vertigo—Methotrexate—psoriatic arthritis	0.000816	0.00156	CcSEcCtD
Dipyridamole—Urticaria—Dexamethasone—psoriatic arthritis	0.00081	0.00155	CcSEcCtD
Dipyridamole—Urticaria—Betamethasone—psoriatic arthritis	0.00081	0.00155	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000809	0.00154	CcSEcCtD
Dipyridamole—Dizziness—Prednisolone—psoriatic arthritis	0.000808	0.00154	CcSEcCtD
Dipyridamole—Asthenia—Triamcinolone—psoriatic arthritis	0.000806	0.00154	CcSEcCtD
Dipyridamole—Abdominal pain—Betamethasone—psoriatic arthritis	0.000806	0.00154	CcSEcCtD
Dipyridamole—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000806	0.00154	CcSEcCtD
Dipyridamole—Asthenia—Methylprednisolone—psoriatic arthritis	0.000804	0.00154	CcSEcCtD
Dipyridamole—Paraesthesia—Prednisone—psoriatic arthritis	0.000797	0.00152	CcSEcCtD
Dipyridamole—Pruritus—Triamcinolone—psoriatic arthritis	0.000795	0.00152	CcSEcCtD
Dipyridamole—Cough—Methotrexate—psoriatic arthritis	0.000793	0.00151	CcSEcCtD
Dipyridamole—Pruritus—Methylprednisolone—psoriatic arthritis	0.000793	0.00151	CcSEcCtD
Dipyridamole—Convulsion—Methotrexate—psoriatic arthritis	0.000787	0.0015	CcSEcCtD
Dipyridamole—Dyspepsia—Prednisone—psoriatic arthritis	0.000781	0.00149	CcSEcCtD
Dipyridamole—Chest pain—Methotrexate—psoriatic arthritis	0.000774	0.00148	CcSEcCtD
Dipyridamole—Arthralgia—Methotrexate—psoriatic arthritis	0.000774	0.00148	CcSEcCtD
Dipyridamole—Myalgia—Methotrexate—psoriatic arthritis	0.000774	0.00148	CcSEcCtD
Dipyridamole—Rash—Prednisolone—psoriatic arthritis	0.00077	0.00147	CcSEcCtD
Dipyridamole—Dermatitis—Prednisolone—psoriatic arthritis	0.000769	0.00147	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000768	0.00147	CcSEcCtD
Dipyridamole—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000767	0.00146	CcSEcCtD
Dipyridamole—Fatigue—Prednisone—psoriatic arthritis	0.000765	0.00146	CcSEcCtD
Dipyridamole—Headache—Prednisolone—psoriatic arthritis	0.000765	0.00146	CcSEcCtD
Dipyridamole—Discomfort—Methotrexate—psoriatic arthritis	0.000764	0.00146	CcSEcCtD
Dipyridamole—Dizziness—Triamcinolone—psoriatic arthritis	0.000743	0.00142	CcSEcCtD
Dipyridamole—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000742	0.00142	CcSEcCtD
Dipyridamole—Dizziness—Methylprednisolone—psoriatic arthritis	0.000741	0.00142	CcSEcCtD
Dipyridamole—Feeling abnormal—Prednisone—psoriatic arthritis	0.000731	0.0014	CcSEcCtD
Dipyridamole—Asthenia—Betamethasone—psoriatic arthritis	0.000731	0.0014	CcSEcCtD
Dipyridamole—Asthenia—Dexamethasone—psoriatic arthritis	0.000731	0.0014	CcSEcCtD
Dipyridamole—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000727	0.00139	CcSEcCtD
Dipyridamole—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000726	0.00139	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000726	0.00139	CcSEcCtD
Dipyridamole—Nausea—Prednisolone—psoriatic arthritis	0.000725	0.00139	CcSEcCtD
Dipyridamole—Pruritus—Betamethasone—psoriatic arthritis	0.000721	0.00138	CcSEcCtD
Dipyridamole—Pruritus—Dexamethasone—psoriatic arthritis	0.000721	0.00138	CcSEcCtD
Dipyridamole—Skin disorder—Methotrexate—psoriatic arthritis	0.00072	0.00138	CcSEcCtD
Dipyridamole—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000717	0.00137	CcSEcCtD
Dipyridamole—Vomiting—Triamcinolone—psoriatic arthritis	0.000714	0.00136	CcSEcCtD
Dipyridamole—Vomiting—Methylprednisolone—psoriatic arthritis	0.000712	0.00136	CcSEcCtD
Dipyridamole—Rash—Triamcinolone—psoriatic arthritis	0.000708	0.00135	CcSEcCtD
Dipyridamole—Dermatitis—Triamcinolone—psoriatic arthritis	0.000707	0.00135	CcSEcCtD
Dipyridamole—Rash—Methylprednisolone—psoriatic arthritis	0.000707	0.00135	CcSEcCtD
Dipyridamole—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000706	0.00135	CcSEcCtD
Dipyridamole—Urticaria—Prednisone—psoriatic arthritis	0.000705	0.00135	CcSEcCtD
Dipyridamole—Headache—Triamcinolone—psoriatic arthritis	0.000704	0.00134	CcSEcCtD
Dipyridamole—Headache—Methylprednisolone—psoriatic arthritis	0.000702	0.00134	CcSEcCtD
Dipyridamole—Abdominal pain—Prednisone—psoriatic arthritis	0.000702	0.00134	CcSEcCtD
Dipyridamole—Diarrhoea—Betamethasone—psoriatic arthritis	0.000697	0.00133	CcSEcCtD
Dipyridamole—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000697	0.00133	CcSEcCtD
Dipyridamole—Hypotension—Methotrexate—psoriatic arthritis	0.000693	0.00132	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000676	0.00129	CcSEcCtD
Dipyridamole—Dizziness—Dexamethasone—psoriatic arthritis	0.000674	0.00129	CcSEcCtD
Dipyridamole—Dizziness—Betamethasone—psoriatic arthritis	0.000674	0.00129	CcSEcCtD
Dipyridamole—Nausea—Triamcinolone—psoriatic arthritis	0.000667	0.00127	CcSEcCtD
Dipyridamole—Paraesthesia—Methotrexate—psoriatic arthritis	0.000666	0.00127	CcSEcCtD
Dipyridamole—Nausea—Methylprednisolone—psoriatic arthritis	0.000666	0.00127	CcSEcCtD
Dipyridamole—Dyspnoea—Methotrexate—psoriatic arthritis	0.000661	0.00126	CcSEcCtD
Dipyridamole—Somnolence—Methotrexate—psoriatic arthritis	0.000659	0.00126	CcSEcCtD
Dipyridamole—Hypersensitivity—Prednisone—psoriatic arthritis	0.000654	0.00125	CcSEcCtD
Dipyridamole—Dyspepsia—Methotrexate—psoriatic arthritis	0.000653	0.00125	CcSEcCtD
Dipyridamole—Vomiting—Dexamethasone—psoriatic arthritis	0.000648	0.00124	CcSEcCtD
Dipyridamole—Vomiting—Betamethasone—psoriatic arthritis	0.000648	0.00124	CcSEcCtD
Dipyridamole—Rash—Dexamethasone—psoriatic arthritis	0.000642	0.00123	CcSEcCtD
Dipyridamole—Rash—Betamethasone—psoriatic arthritis	0.000642	0.00123	CcSEcCtD
Dipyridamole—Dermatitis—Betamethasone—psoriatic arthritis	0.000642	0.00123	CcSEcCtD
Dipyridamole—Dermatitis—Dexamethasone—psoriatic arthritis	0.000642	0.00123	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00064	0.00122	CcSEcCtD
Dipyridamole—Fatigue—Methotrexate—psoriatic arthritis	0.000639	0.00122	CcSEcCtD
Dipyridamole—Headache—Dexamethasone—psoriatic arthritis	0.000638	0.00122	CcSEcCtD
Dipyridamole—Headache—Betamethasone—psoriatic arthritis	0.000638	0.00122	CcSEcCtD
Dipyridamole—Asthenia—Prednisone—psoriatic arthritis	0.000637	0.00122	CcSEcCtD
Dipyridamole—Pain—Methotrexate—psoriatic arthritis	0.000634	0.00121	CcSEcCtD
Dipyridamole—Pruritus—Prednisone—psoriatic arthritis	0.000628	0.0012	CcSEcCtD
Dipyridamole—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000611	0.00117	CcSEcCtD
Dipyridamole—Diarrhoea—Prednisone—psoriatic arthritis	0.000607	0.00116	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000606	0.00116	CcSEcCtD
Dipyridamole—Nausea—Dexamethasone—psoriatic arthritis	0.000605	0.00116	CcSEcCtD
Dipyridamole—Nausea—Betamethasone—psoriatic arthritis	0.000605	0.00116	CcSEcCtD
Dipyridamole—Urticaria—Methotrexate—psoriatic arthritis	0.000589	0.00113	CcSEcCtD
Dipyridamole—Dizziness—Prednisone—psoriatic arthritis	0.000587	0.00112	CcSEcCtD
Dipyridamole—Abdominal pain—Methotrexate—psoriatic arthritis	0.000586	0.00112	CcSEcCtD
Dipyridamole—Vomiting—Prednisone—psoriatic arthritis	0.000564	0.00108	CcSEcCtD
Dipyridamole—Rash—Prednisone—psoriatic arthritis	0.00056	0.00107	CcSEcCtD
Dipyridamole—Dermatitis—Prednisone—psoriatic arthritis	0.000559	0.00107	CcSEcCtD
Dipyridamole—Headache—Prednisone—psoriatic arthritis	0.000556	0.00106	CcSEcCtD
Dipyridamole—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000546	0.00104	CcSEcCtD
Dipyridamole—Asthenia—Methotrexate—psoriatic arthritis	0.000532	0.00102	CcSEcCtD
Dipyridamole—Nausea—Prednisone—psoriatic arthritis	0.000527	0.00101	CcSEcCtD
Dipyridamole—Pruritus—Methotrexate—psoriatic arthritis	0.000525	0.001	CcSEcCtD
Dipyridamole—Diarrhoea—Methotrexate—psoriatic arthritis	0.000507	0.000969	CcSEcCtD
Dipyridamole—Dizziness—Methotrexate—psoriatic arthritis	0.00049	0.000937	CcSEcCtD
Dipyridamole—Vomiting—Methotrexate—psoriatic arthritis	0.000472	0.000901	CcSEcCtD
Dipyridamole—Rash—Methotrexate—psoriatic arthritis	0.000468	0.000893	CcSEcCtD
Dipyridamole—Dermatitis—Methotrexate—psoriatic arthritis	0.000467	0.000892	CcSEcCtD
Dipyridamole—Headache—Methotrexate—psoriatic arthritis	0.000465	0.000887	CcSEcCtD
Dipyridamole—Nausea—Methotrexate—psoriatic arthritis	0.000441	0.000841	CcSEcCtD
